Literature DB >> 20640889

Caspase-3 triggers a TPCK-sensitive protease pathway leading to degradation of the BH3-only protein puma.

Abbas Hadji1, Cyril Clybouw, Marie-Thérèse Auffredou, Catherine Alexia, Konstantinos Poalas, Aude Burlion, Olivier Feraud, Gérald Leca, Aimé Vazquez.   

Abstract

The protein Puma (p53-upregulated modulator of apoptosis) belongs to the BH3-only group of the Bcl-2 family and is a major regulator of apoptosis. Although the transcriptional regulation of Puma is clearly established, little is known about the regulation of its expression at the protein levels. We show here that various signals--including the cytokine TGFβ, the death effector TRAIL or chemical drugs such as anisomycin--downregulate Puma protein levels via a novel pathway based on the sequential activation of caspase-3 and a protease inhibited by the serpase inhibitor N-tosyl-L-phenylalanine chloromethyl ketone. This pathway is specific for Puma because (1) the levels of other BH3-only proteins, such as Bim and Noxa were not modified by these stimuli and (2) this caspase-mediated degradation was dependent on both the BH3 and C-terminal domains of Puma. Our data also show that Puma is regulated during the caspase-3-dependent differentiation of murine embryonic stem cells and suggest that this pathway may be relevant and important during caspase-mediated cell differentiation not associated with apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640889     DOI: 10.1007/s10495-010-0528-2

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  5 in total

1.  Regulation of memory B-cell survival by the BH3-only protein Puma.

Authors:  Cyril Clybouw; Silke Fischer; Marie Thérèse Auffredou; Patricia Hugues; Catherine Alexia; Philippe Bouillet; Martine Raphael; Gérald Leca; Andreas Strasser; David M Tarlinton; Aimé Vazquez
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

2.  EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.

Authors:  Amber Bradley; Hui Zheng; Angela Ziebarth; Wayne Sakati; Melissa Branham-O'Connor; Joe B Blumer; Yuying Liu; Emily Kistner-Griffin; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Anil K Sood; Charles N Landen; Scott T Eblen
Journal:  Carcinogenesis       Date:  2013-12-30       Impact factor: 4.944

3.  Synergistic killing of colorectal cancer cells by oxaliplatin and ABT-737.

Authors:  Daniëlle A E Raats; Menno T de Bruijn; Ernst J A Steller; Benjamin L Emmink; Inne H M Borel-Rinkes; Onno Kranenburg
Journal:  Cell Oncol (Dordr)       Date:  2011-04-06       Impact factor: 6.730

4.  Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.

Authors:  Gorbatchev Ambroise; Alain Portier; Nathalie Roders; Damien Arnoult; Aimé Vazquez
Journal:  Oncotarget       Date:  2015-11-10

5.  Lithocholic acid induces endoplasmic reticulum stress, autophagy and mitochondrial dysfunction in human prostate cancer cells.

Authors:  Ahmed A Gafar; Hossam M Draz; Alexander A Goldberg; Mohamed A Bashandy; Sayed Bakry; Mahmoud A Khalifa; Walid AbuShair; Vladimir I Titorenko; J Thomas Sanderson
Journal:  PeerJ       Date:  2016-11-15       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.